Expression of endothelial nitric oxide synthase traffic inducer in the pladenta of pregnancy induced hypertension

Abstract

The expression of endothelial nitric oxide synthase traffic inducer (NOSTRIN) in the placenta of the patients with pregnancy induced hypertension (PIH) was detected and its role in the pathogenesis of PIH was studied. The pathological changes in placental vessels were observed by HE staining, NO₂₋/NO₃₋, the stable metabolic end products of NO, was measured with nitrate reductase. The eNOS activity in placental tissues was assayed by spectrophotometry. Western blot analysis was applied to detect NOSTRIN expression. The incidence of thickening and fibronoid necrosis of placental vessels was significantly higher in women with PIH than in the normal group (P<0.01). The levels of placental NO₂₋/NO₃₋ in PIH patients (27.53±7.48 μmol/mg) were significantly lower than in normal group (54.27±9.53 μmol/mg,P<0.01). The activity of eNOS was significantly decreased in PIH group (12.826±3.61 U/mg) as compared with that in normal group (21.72±3.83 U/mg,P<0.01). Western blot analysis revealed that both groups expressed 58 kD NOSTRIN, but the protein level was significantly higher in women with PIH than in the normal group (P<0.01). A significant negative correlation existed between the expression of NOSTRIN protein and the activity of eNOS in placental tissue of women with PIH (r=−0.57,P<0.01). It was concluded that the level of NOSTRIN expression in placenta of women with PIH was increased, which may play an important role in the pathogenesis of PIH.

Keywords

endothelial nitric oxide synthase traffic inducer / nitric oxide synthase / placenta / pregnancy induced hypertension

References

[1] ZimmermannK, OpitzN, DedioJ. NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc Notl Acad Sci USA, 2004, 99(26): 16150-16512

[2] HarlowE, LaneD. Antibodies: A Laboratory Manual, 1988, NY, Cold Spring Harbor Laboratory: 72-72

[3] SeligmanS P, BuyonJ P, ClancyR M. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol, 1994, 171: 944-948

[4] VarA, YildirimY, OnurE, et al.. Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels. Gynecol Obstet Invest, 2003, 56(4): 221-224

[5] MyattL, BrewerA S, LangdonG, et al.. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol, 1992, 166: 224-230

[6] De GraafJ C, BangJ D, MoncadaS, et al.. Nitric oxide as an inhibitor of platelet adhesion under flow conditions. Circulation, 1992, 85: 2284-2290

[7] SladekS M, MagnessR R, ConradK P. Nitric oxide and pregnancy. Am J Physiol, 1997, 272: R441-R463

[8] TongX, LiS, ZhaoY. Expression of endothelial nitric oxide synthase gene in placental villus of preeclampsia. Zhonghua Fu Chan Ke Za Zhi, 1998, 33(9): 527-528